SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

By M. Cowie, M. Fisher. Nature Reviews Cardiology, 2020

662 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/ee3e8c5f5352e2fcb575402481efdf9dbf3cd7df